PMID- 14685779 OWN - NLM STAT- MEDLINE DCOM- 20040331 LR - 20240426 IS - 0340-7004 (Print) IS - 1432-0851 (Electronic) IS - 0340-7004 (Linking) VI - 53 IP - 3 DP - 2004 Mar TI - Dendritic cell biology and cancer therapy. PG - 240-8 AB - Dendritic cells (DCs) are nature's best antigen-presenting cells. They possess attributes that allow them to effectively fulfill the requirements for priming/activating T cells and mediating tumor-specific immune responses. In this review, emphasis is placed on those aspects of DC biology that best illustrate their usefulness in immunotherapy of cancer. Culture, maturation, and polarization conditions for human DC are discussed, as are strategies for antigen-loading of DCs and for their delivery to patients with cancer. A concise recommendation for monitoring of DC-based vaccination trails is provided. FAU - Whiteside, Theresa L AU - Whiteside TL AD - Research Pavilion at the Hillman Cancer Center, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Suite 1.27, PA 15213-1863, Pittsburgh, USA. whitesidetl@msx.upmc.edu FAU - Odoux, Christine AU - Odoux C LA - eng PT - Journal Article PT - Review DEP - 20031218 PL - Germany TA - Cancer Immunol Immunother JT - Cancer immunology, immunotherapy : CII JID - 8605732 RN - 0 (Antigens, Neoplasm) SB - IM MH - Animals MH - Antigens, Neoplasm/immunology MH - Cell Movement MH - Cells, Cultured MH - Dendritic Cells/immunology/*physiology MH - Humans MH - Immunotherapy/*methods MH - Neoplasms/*therapy PMC - PMC11034253 EDAT- 2003/12/20 05:00 MHDA- 2004/04/01 05:00 PMCR- 2003/12/18 CRDT- 2003/12/20 05:00 PHST- 2003/09/12 00:00 [received] PHST- 2003/10/24 00:00 [accepted] PHST- 2003/12/20 05:00 [pubmed] PHST- 2004/04/01 05:00 [medline] PHST- 2003/12/20 05:00 [entrez] PHST- 2003/12/18 00:00 [pmc-release] AID - 468 [pii] AID - 10.1007/s00262-003-0468-6 [doi] PST - ppublish SO - Cancer Immunol Immunother. 2004 Mar;53(3):240-8. doi: 10.1007/s00262-003-0468-6. Epub 2003 Dec 18.